Symeres – Making Molecules Matter. Together.

Making Molecules Matter.Together.

Ask anything

Making Molecules Matter.Together.

We are the leading transatlantic small molecule contract research and manufacturing organization that has been a trusted global partner for biotech and pharma companies for over 30 years.

About us

Symeres is the leading mid-sized transatlantic Contract Research Organization for your drug discovery and development challenges.

With over 600 highly educated scientists in six locations in Europe and two in the USA, we offer best-in-class solutions for drug discovery and drug development, from small to medium-sized molecule hits. We are large enough to matter, and small enough to care.

Our services span across early stage hit finding all the way to the delivery of your early clinical drug substance API. Making Molecules Matter. Together.

Why work with us?

Symeres offers a range of services in the fields of integrated drug discovery and development, from early hit synthesis to GMP manufacturing, via medicinal chemistry, in vitro pharmacology assays, ADME-Tox and PK via our Admescope platform, process research and development and supporting early formulation and solid-state chemistry. All underpinned by consolidated experience in the custom synthesis services.

World-class expertise in innovative drug discovery, drug development and synthetic organic chemistry
>30 years track record of successful project progression for our clients
High staff retention means highly experienced teams
Creative and adaptive problem-solving
Excellence in communication
Trusted partner network for additional platforms
Laboratories in Europe and United States

Vacancies

A career at Symeres is unlike any other. Groundbreaking research, inspiring clients, motivating projects and being part of talented teams. So if you’re an outstanding talent with a need to discover the solutions to all kinds of fascinating challenges, we want to hear from you.

View our vacancies

Latest news

Below are a few of our most recent news items.

“If the compound can be made, Symeres will undoubtedly find out a good way to make it.”

An in-depth interview with Doo Young Jung, the founder and CEO of our client PinotBio in South Korea, focused on the challenge of cancer resistance/relapse

Read more
An interview with Yadan Chen and Paul O’Shea

We are pleased to introduce the founders of Symeres’ daughter company Exemplify in New Jersey: Yadan Chen, CEO, and Paul O’Shea, Chief Scientific Officer. Who are they? What do they stand for? And how does Exemplify fit with Symeres?

Read more

Latest events

Symeres actively participates in many international Life Sciences conferences. See below for some of the upcoming events where you can meet us and discuss your R&D services needs.